- Involvement of c-Src activity in the mTOR-dependent oncogenicity of melanoma cellsPublication without faculty affiliation
- Activity of c-Src as a novel target for the inhibition of mTOR signaling in human diseasesPublication without faculty affiliation
- Treatment of tumors with NTRK fusions2021 | First Faculty of Medicine
- The pool of preactivated Lck in the initiation of T-cell signaling: a critical re-evaluation of the Lck standby model2015 | Faculty of Science
- A radioligand binding assay for the insulin-like growth factor 2 receptor2020 | Faculty of Science
- Targeted therapeutics and their role in the treatment of internal diseases2013 | First Faculty of Medicine
- Gastrointestinal stromal tumours (GIST)2005 | First Faculty of Medicine
- Erlotinib in the treatment of advanced non-small cell lung cancer - present experience and results in the Czech Repuiblic2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia2018 | First Faculty of Medicine, Central Library of Charles University
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.2018 | First Faculty of Medicine, Central Library of Charles University
- Is there a benefit of HER2-positive breast cancer subtype determination in clinical practice?2019 | First Faculty of Medicine, Third Faculty of Medicine